Medwell Capital Corp.

MWC-X

0.00
0.00 (0.00%)
This company is not ACTIVE.

Analysis and Opinions about MWC-X

Signal
Opinion
Expert
SPECULATIVE BUY
SPECULATIVE BUY
January 26, 2009
Very interesting biotechnology targeted to MS. Ranks well in his model at 15 because of the strong performance of the stock. Early-stage company.
Show full opinionHide full opinion
Very interesting biotechnology targeted to MS. Ranks well in his model at 15 because of the strong performance of the stock. Early-stage company.
COMMENT
COMMENT
January 24, 2007
In phase 3 pivotal trial for secondary progressive MS and about a year away from getting data. Just got FDA approval to start trials in the US. Very high Risk and very high Reward.
Show full opinionHide full opinion
In phase 3 pivotal trial for secondary progressive MS and about a year away from getting data. Just got FDA approval to start trials in the US. Very high Risk and very high Reward.
Showing 1 to 2 of 2 entries
  • «
  • 1
  • »